BIRC5 and ovarian cancer: Western blot analyses indicated that Sp1 could significantly elevate the expression levels of survivin as well as XIAP, while KLF12 had the opposite effects compared to Sp1 and suppressed survivin and XIAP expressions in both ovarian cancer cell lines (Fig. 6f).